Affiliation:
1. Russian Medical Academy of Continuous Professional Education
2. Russian Medical Academy of Continuous Professional Education;
I. M. Sechenov First Moscow State Medical University
3. I. M. Sechenov First Moscow State Medical University
Abstract
Some patients are more likely to have drug-induced diseases due to a number of risk factors, such as older age. The aim of the study was to analyse the effect of older age on pharmacokinetics and pharmacodynamics of medicines and the risk of developing drug-induced diseases. The analysis of scientific literature demonstrated that changes in the functions of body organs and systems caused by natural aging processes may potentially affect pharmacokinetics and pharmacodynamics of medicines and increase the risk of adverse drug reactions. For instance, older people have a decreased cardiac output both at rest and during exercise, weight loss, loss of elasticity of elastic vessels, a reduced number of functioning nephrons, poorer renal filtration capacity, decreased liver volume, a reduced number of functioning hepatocytes, decreased hepatic blood flow. These changes directly affect absorption, metabolism, distribution, and excretion of medicines, which in turn can affect their safety profiles. Consideration of age-related changes in the functions of body organs and systems, regular monitoring of the efficacy and safety of the prescribed medicine, changing the dosage regimen, and revision of the treatment sheet by healthcare professionals will help optimize pharmacotherapy and reduce the risk of adverse reactions and drug-induced diseases in older patients.
Reference29 articles.
1. Astakhova AV, Lepakhin VK. Drugs. Adverse drug reactions and safety control. 2nd ed. Moscow: Eksmo; 2008 (In Russ.)
2. Sychev DA, Ostroumova OD, Kochetkov AI, Pereverzev AP, Ostroumova TM, Klepikova MV, et al. Drug-induced diseases: epidemiology and urgency of the problem. Farmateka. 2020;27(5):77–84 (In Russ.) https://dx.doi.org/10.18565/pharmateca.2020.5.77-84
3. Angamo MT, Chalmers L, Curtain CM, Bereznicki LR. Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf. 2016;39(9):847–57. https://doi.org/10.1007/s40264-016-0444-7
4. Hakkarainen KM, Gyllensten H, Jönsson AK, Andersson Sundell K, Petzold M, Hägg S. Prevalence, nature and potential preventability of adverse drug events — a population-based medical record study of 4970 adults. Br J Clin Pharmacol. 2014;78(1):170– 83. https://doi.org/10.1111/bcp.12314
5. Tisdale JE, Miller DA. Drug-induced diseases: prevention, detection, and management. 3rd ed. Bethesda, Md.: American Society of Health-System Pharmacists; 2018.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献